You are here

  • Home
  • Archive
  • Volume 26, Issue 4
  • Tolerance and safety of rapid 2-hour infusion of rituximab in patients with kidney-affecting autoimmune diseases and glomerulonephritides: a single-centre experience

Article metrics

Article menu
Download PDFPDF
Original article
Tolerance and safety of rapid 2-hour infusion of rituximab in patients with kidney-affecting autoimmune diseases and glomerulonephritides: a single-centre experience

 

Online download statistics by month:

Online download statistics by month: February 2018 to March 2024

AbstractFullPdf
Feb 20183921
Mar 20183871414
Apr 201830846
May 201819111
Jun 20185200
Jul 20181231213
Aug 20185733
Sep 20185400
Oct 20184208
Nov 20186813
Dec 201810701
Jan 20198411
Feb 20198912
Mar 20193930
Apr 20196401
May 20192600
Jun 20199522
Jul 20194211512
Aug 2019354128
Sep 201921553
Oct 201916521
Nov 201910452
Dec 20199753
Jan 20209811
Feb 20206900
Mar 202010135
Apr 20205511
May 20206722
Jun 20207922
Jul 20204210
Aug 20203200
Sep 202011100
Oct 20205301
Nov 20204000
Dec 20205300
Jan 20217300
Feb 20213100
Mar 20218700
Apr 20212400
May 20211100
Jun 2021100
Jul 2021100
Sep 2021320
Oct 20212600
Nov 20215000
Dec 20214440
Jan 20221700
Feb 20223700
Mar 202214910
Apr 20225400
May 20229700
Jun 20225820
Jul 20224310
Aug 20229200
Sep 20229910
Oct 202210311
Nov 20223910
Dec 20225900
Jan 20232821
Feb 20238400
Mar 20234220
Apr 20235700
May 20232010
Jun 20233301
Jul 20231600
Aug 20232320
Sep 20232300
Oct 20233820
Nov 20231111
Dec 20236201
Jan 20241602
Feb 20243600
Mar 20249923
Total5767123107